384
Views
13
CrossRef citations to date
0
Altmetric
Research Papers

“It’s a Hidden Issue”: Exploring the experiences of women with HIV-associated neurocognitive challenges using a disability framework

, , , , , & show all
Pages 36-46 | Received 06 Aug 2011, Accepted 17 Apr 2012, Published online: 24 May 2012

References

  • Palella FJ Jr, Deloria-Knoll M, Chmiel JS, Moorman AC, Wood KC, Greenberg AE, Holmberg SD; HIV Outpatient Study Investigators. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med 2003;138:620–626.
  • O’Brien KK, Bayoumi AM, Strike C, Young NL, Davis AM. Exploring disability from the perspective of adults living with HIV/AIDS: development of a conceptual framework. Health Qual Life Outcomes 2008;6:76.
  • Worthington C, Myers T, O’Brien K, Nixon S, Cockerill R. Rehabilitation in HIV/AIDS: development of an expanded conceptual framework. AIDS Patient Care STDS 2005;19:258–271.
  • Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007;69:1789–1799.
  • Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a working group of the american academy of neurology AIDS task force. Neurology 1991;41:778–785.
  • González-Scarano F, Martín-García J. The neuropathogenesis of AIDS. Nat Rev Immunol 2005;5:69–81.
  • Grant I. Neurocognitive disturbances in HIV. Int Rev Psychiatry 2008;20:33–47.
  • McArthur JC. HIV dementia: an evolving disease. J Neuroimmunol 2004;157:3–10.
  • Foley J, Ettenhofer M, Wright M, Hinkin CH. Emerging issues in the neuropsychology of HIV infection. Curr HIV/AIDS Rep 2008;5:204–211.
  • Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, et al. CHARTER Group. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008;65:65–70.
  • Correlates of CSF viral loads in 1221 volunteers of the CHARTER cohort. 17th conference on retroviruses & opportunistic infections (CROI 2010); February 16–19, 2010.
  • Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, et al. CHARTER Group; HNRC Group. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 2011;17:3–16.
  • Rourke SB, Halman MH, Bassel C. Neuropsychiatric correlates of memory-metamemory dissociations in HIV-infection. J Clin Exp Neuropsychol 1999;21:757–768.
  • Carter SL, Rourke SB, Murji S, Shore D, Rourke BP. Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis. Neuropsychology 2003;17:410–419.
  • Millikin CP, Rourke SB, Halman MH, Power C. Fatigue in HIV/AIDS is associated with depression and subjective neurocognitive complaints but not neuropsychological functioning. J Clin Exp Neuropsychol 2003;25:201–215.
  • Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 2007;27:86–92.
  • Mehta P, Gulevich SJ, Thal LJ, Jin H, Olichney JM, McCutchan JA, Heaton RK, et al. Neurological Symptoms, Not Signs, Are Common in Early HIV Infection. J NeuroAIDS 1996;1:67–85.
  • Woods SP, Iudicello JE, Moran LM, Carey CL, Dawson MS, Grant I; HIV Neurobehavioral Research Center Group. HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology 2008;22:110–117.
  • Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA et al.; HNRC Group. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 2004;10:317–331.
  • Morgan EE, Woods SP, Weber E, Dawson MS, Carey CL, Moran LM, Grant I; HIV Neurobehavioral Research Center (HNRC) Group. HIV-associated episodic memory impairment: evidence of a possible differential deficit in source memory for complex visual stimuli. J Neuropsychiatry Clin Neurosci 2009;21:189–198.
  • Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, Godfrey HP, et al. Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med 1994;56:8–17.
  • Albert SM, Marder K, Dooneief G, Bell K, Sano M, Todak G, Stern Y. Neuropsychologic impairment in early HIV infection. A risk factor for work disability. Arch Neurol 1995;52:525–530.
  • Trépanier LL, Rourke SB, Bayoumi AM, Halman MH, Krzyzanowski S, Power C. The impact of neuropsychological impairment and depression on health-related quality of life in HIV-infection. J Clin Exp Neuropsychol 2005;27:1–15.
  • Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I, HNRC G. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 2004; 10:317–331.
  • Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, Thrasher D, et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology 2002;59:1944–1950.
  • Mayeux R, Stern Y, Tang MX, Todak G, Marder K, Sano M, Richards M, et al. Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology 1993;43:176–182.
  • Vivithanaporn P, Heo G, Gamble J, Krentz HB, Hoke A, Gill MJ, Power C. Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology 2010;75:1150–1158.
  • Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, Abramson I, et al. Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol 1997;54:416–424.
  • Gorman AA, Foley JM, Ettenhofer ML, Hinkin CH, van Gorp WG. Functional consequences of HIV-associated neuropsychological impairment. Neuropsychol Rev 2009;19:186–203.
  • Clifford DB. HIV-associated neurocognitive disease continues in the antiretroviral era. Top HIV Med 2008;16:94–98.
  • Brew BJ, Pemberton L, Ray J. Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs? J Neurovirol 2004;10 Suppl 1:38–43.
  • Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 2009;19:152–168.
  • Osowiecki DM, Cohen RA, Morrow KM, Paul RH, Carpenter CC, Flanigan T, Boland RJ. Neurocognitive and psychological contributions to quality of life in HIV-1-infected women. AIDS 2000;14:1327–1332.
  • Canadian Working Group on HIV and Rehabilitation (2010). HIV, disability and rehabilitation: Promoting quality of life through research, education and cross-sector partnerships. Strategic plan: 2010–2013.
  • Faílde-Garrido JM, Alvarez MR, Simón-López MA. Neuropsychological impairment and gender differences in HIV-1 infection. Psychiatry Clin Neurosci 2008;62:494–502.
  • Maki PM, Martin-Thormeyer E. HIV, cognition and women. Neuropsychol Rev 2009;19:204–214.
  • HIV/AIDS Statistics - Ontario [Internet] [cited 2009 10/2/2009]. Available from: http://www.actoronto.org/home.nsf/pages/hivaidsstatsont.
  • HIV/AIDS Statistics - Canada [Internet] [cited 2009 10/2/2009]. Available from: http://www.actoronto.org/home.nsf/pages/hivaidsstatscan.
  • UNAIDS report on the global AIDS epidemic [Internet] [cited 2011 7/17/2011]. Available from: http://www.unaids.org/globalreport/.
  • Morgello S, Mahboob R, Yakoushina T, Khan S, Hague K. Autopsy findings in a human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors, and time. Arch Pathol Lab Med 2002;126:182–190.
  • Farzadegan H, Hoover DR, Astemborski J, Lyles CM, Margolick JB, Markham RB, Quinn TC, Vlahov D. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998;352:1510–1514.
  • Wojna V, Skolasky RL, Hechavarría R, Mayo R, Selnes O, McArthur JC, Meléndez LM, et al. Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol 2006;12:356–364.
  • Solomon P, Wilkins S. Participation among women living with HIV: a rehabilitation perspective. AIDS Care 2008;20:292–296.
  • Basso MR, Bornstein RA. Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12 months. J Clin Exp Neuropsychol 2000;22:208–218.
  • Chiesi A, Vella S, Dally LG, Pedersen C, Danner S, Johnson AM, Schwander S, et al. Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:39–44.
  • ICF: International classification of functioning, disability and health. Short version. ed. Geneva: World Health Organization; 2001.
  • Coenen M, Cieza A, Stamm TA, Amann E, Kollerits B, Stucki G. Validation of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis from the patient perspective using focus groups. Arthritis Res Ther 2006;8:R84.
  • Hieblinger R, Coenen M, Stucki G, Winkelmann A, Cieza A. Validation of the International Classification of Functioning, Disability and Health Core Set for chronic widespread pain from the perspective of fibromyalgia patients. Arthritis Res Ther 2009;11:R67.
  • Kirchberger I, Coenen M, Hierl FX, Dieterle C, Seissler J, Stucki G, Cieza A. Validation of the International Classification of Functioning, Disability and Health (ICF) core set for diabetes mellitus from the patient perspective using focus groups. Diabet Med 2009;26:700–707.
  • Nixon S, Cott CA. “Shifting perspectives”: Reconceptualizing HIV disease in a rehabilitation framework. Physiotherapy Canada 2000;52:189–197.
  • Rusch M, Nixon S, Schilder A, Braitstein P, Chan K, Hogg RS. Impairments, activity limitations and participation restrictions: prevalence and associations among persons living with HIV/AIDS in British Columbia. Health Qual Life Outcomes 2004;2:46.
  • Sanders LB. Women’s voices: the lived experience of pregnancy and motherhood after diagnosis with HIV. J Assoc Nurses AIDS Care 2008;19:47–57.
  • Denzin N, Lys K. Handbook of qualitative research. 2nd edition. ed. Thousand Oaks, CA: Sage Publications, 2000.
  • Creswell JW. Qualitative inquiry and research design. Thousand Oaks, CA: Sage; 1998.
  • Patton MQ. Qualitative evaluation methods. 2nd edition. Thousand Oaks, CA: Sage; 1990.
  • Cohen RA, Boland R, Paul R, Tashima KT, Schoenbaum EE, Celentano DD, Schuman P, et al. Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS 2001;15:341–345.
  • Gonzalez R, Cherner M. Co-factors in HIV neurobehavioural disturbances: substance abuse, hepatitis C and aging. Int Rev Psychiatry 2008;20:49–60.
  • O’Brien K, Wilkins A, Zack E, Solomon P. Scoping the field: identifying key research priorities in HIV and rehabilitation. AIDS Behav 2010;14:448–458.
  • Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychology Review 2009; 19:152–168.
  • Solomon P, Wilkins S. Participation among women living with HIV: A rehabilitation perspective. AIDS Care 2008; 20:292–296.
  • Loutfy MR, Hart TA, Mohammed SS, Su D, Ralph ED, Walmsley SL, Soje LC et al.; Ontario HIV Fertility Research Team. Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional study. PLoS ONE 2009;4:e7925.
  • Vance DE. Aging with HIV: clinical considerations for an emerging population. Am J Nurs 2010;110:42–7; quiz 48.
  • O’Brien KK, Bayoumi AM, Davis AM, Young NL, Strike C. Using exploratory focus groups to establish a sampling strategy to investigate disability experienced by adults living with HIV. Curr HIV Res 2009;7:626–633.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.